Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Metal organic frameworks-based scaffolds show promise for tissue repair due to their unique properties.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Nanoparticles can speed up wound healing and deliver drugs effectively but may have potential toxicity risks.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The skin has multiple layers and cells, serves as a protective barrier, helps regulate temperature, enables sensation, affects appearance, and is involved in vitamin D synthesis.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Understanding the properties of hyaluronic acid helps improve its use in facial aging treatments.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Tailored nonsurgical cosmetic procedures are crucial for safely treating diverse skin types, especially skin of color.

Fibroblast-derived growth factors and exosomes can significantly improve skin aging.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

PBMCsec can help reduce and improve thick skin scars.

Activating Nrf2 in skin cells causes skin disease similar to chloracne in mice.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Microneedling combined with skinbooster effectively treats striae rubrae, with confocal microscopy confirming collagen changes.

Endocannabinoids help control mast cell activity in human skin.

Certain mice without specific receptors or mast cells don't lose hair from stress.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Lichen planopilaris involves disrupted fat metabolism, increased scarring, and mast cell activity.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.